Aldose Reductase: A Novel Target for Cardioprotective Interventions

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|4|8|625-632

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.8, 2003-11, pp. : 625-632

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy

By  

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 14-36

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and aldose reductase inhibitory activities of novel dibenzocycloheptenone derivatives

By Inoue J.   Cui Y.-S.   Rodriguez L.   Chen Z.   Kador P.F.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 5, 1999-05 ,pp. : 399-404

Elsevier

Access to resources Recommend Favorite

On the prodrug potential of novel aldose reductase inhibitors with diphenylmethyleneaminooxycarboxylic acid structure

By Rakowitz D.   Matuszczak B.   Gritsch S.   Hofbauer P.   Krassnigg A.   Costantino L.  

European Journal of Pharmaceutical Sciences, Vol. 15, Iss. 1, 2002-02 ,pp. : 11-20

Elsevier

Access to resources Recommend Favorite

Novel aldose reductase inhibitors: a patent survey (2006 – present)

By Chatzopoulou Maria   Alexiou Polyxeni   Kotsampasakou Eleni   Demopoulos Vassilis J  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1303-1323

Informa Healthcare

Access to resources Recommend Favorite

Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1143-1150

Bentham Science Publishers

Access to resources Recommend Favorite